227 related articles for article (PubMed ID: 23176162)
1. Role of probiotics in prevention of Candida infection in critically ill children.
Kumar S; Singhi S
Mycoses; 2013 May; 56(3):204-11. PubMed ID: 23176162
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial.
Kumar S; Bansal A; Chakrabarti A; Singhi S
Crit Care Med; 2013 Feb; 41(2):565-72. PubMed ID: 23361033
[TBL] [Abstract][Full Text] [Related]
3. Oral amphotericin B for the prevention of Candida bloodstream infection in critically ill children.
Ben-Ari J; Samra Z; Nahum E; Levy I; Ashkenazi S; Schonfeld TM
Pediatr Crit Care Med; 2006 Mar; 7(2):115-8. PubMed ID: 16474259
[TBL] [Abstract][Full Text] [Related]
4. Candidemia in the critically ill patient.
Picazo JJ; González-Romo F; Candel FJ
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S83-5. PubMed ID: 19013345
[TBL] [Abstract][Full Text] [Related]
5. [Invasive fungal infection in critically ill patients].
Garnacho-Montero J; Díaz-Martín A; Ruiz-Pérez De Piappón M; García-Cabrera E
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):338-43. PubMed ID: 22503211
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.
Harrison D; Muskett H; Harvey S; Grieve R; Shahin J; Patel K; Sadique Z; Allen E; Dybowski R; Jit M; Edgeworth J; Kibbler C; Barnes R; Soni N; Rowan K
Health Technol Assess; 2013 Feb; 17(3):1-156. PubMed ID: 23369845
[TBL] [Abstract][Full Text] [Related]
7. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.
Steinbach WJ; Roilides E; Berman D; Hoffman JA; Groll AH; Bin-Hussain I; Palazzi DL; Castagnola E; Halasa N; Velegraki A; Dvorak CC; Charkabarti A; Sung L; Danziger-Isakov L; Lachenauer C; Arrieta A; Knapp K; Abzug MJ; Ziebold C; Lehrnbecher T; Klingspor L; Warris A; Leckerman K; Martling T; Walsh TJ; Benjamin DK; Zaoutis TE;
Pediatr Infect Dis J; 2012 Dec; 31(12):1252-7. PubMed ID: 22982980
[TBL] [Abstract][Full Text] [Related]
8. Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
Bailly S; Bouadma L; Azoulay E; Orgeas MG; Adrie C; Souweine B; Schwebel C; Maubon D; Hamidfar-Roy R; Darmon M; Wolff M; Cornet M; Timsit JF
Am J Respir Crit Care Med; 2015 May; 191(10):1139-46. PubMed ID: 25780856
[TBL] [Abstract][Full Text] [Related]
9. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
[TBL] [Abstract][Full Text] [Related]
11. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non- neutropenic critically ill adult patients.
Epico Project Group
Rev Esp Quimioter; 2013 Jun; 26(2):131-50. PubMed ID: 23817652
[TBL] [Abstract][Full Text] [Related]
12. Candida prophylaxis and therapy in the ICU.
Echeverria PM; Kett DH; Azoulay E
Semin Respir Crit Care Med; 2011 Apr; 32(2):159-73. PubMed ID: 21506052
[TBL] [Abstract][Full Text] [Related]
13. Probiotics in critically ill children.
Singhi SC; Kumar S
F1000Res; 2016; 5():. PubMed ID: 27081478
[TBL] [Abstract][Full Text] [Related]
14. The current treatment landscape: candidiasis.
Bassetti M; Peghin M; Timsit JF
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii13-ii22. PubMed ID: 27880665
[TBL] [Abstract][Full Text] [Related]
15. [Invasive candidiasis in critically ill adult patient].
Tobar A E; Silva O F; Olivares C R; Gaete G P; Luppi N M
Rev Chilena Infectol; 2011 Feb; 28(1):41-9. PubMed ID: 21526285
[TBL] [Abstract][Full Text] [Related]
16. Management of candidaemia and invasive candidiasis in critically ill patients.
Chahoud J; Kanafani ZA; Kanj SS
Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S29-35. PubMed ID: 23664579
[TBL] [Abstract][Full Text] [Related]
17. Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units.
Shahin J; Allen EJ; Patel K; Muskett H; Harvey SE; Edgeworth J; Kibbler CC; Barnes RA; Biswas S; Soni N; Rowan KM; Harrison DA;
BMC Infect Dis; 2016 Sep; 16(1):480. PubMed ID: 27612566
[TBL] [Abstract][Full Text] [Related]
18. Invasive fungal infections in the intensive care unit.
Vazquez JA
Semin Respir Crit Care Med; 2010 Feb; 31(1):79-86. PubMed ID: 20101550
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
20. Systemic antifungal therapy in critically ill patients without invasive fungal infection*.
Azoulay E; Dupont H; Tabah A; Lortholary O; Stahl JP; Francais A; Martin C; Guidet B; Timsit JF
Crit Care Med; 2012 Mar; 40(3):813-22. PubMed ID: 22297630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]